A lab at Harvard T.H. Chan School of Public Health received industry-sponsored research and aims to translate discoveries about a protein that helps regulate metabolism and inflammation into novel therapeutics for obesity, heart disease, and age-related illnesses.

Video on how OTD supports Harvard’s mission to bring innovation out of labs to make a real-world impact.

Investigating the reasons behind the stall in the decline of cardiovascular disease deaths in the U.S. and the new scientific innovations emerging from Harvard labs that aim to improve treatment and drive death rates down.

With funding and business development support from the Blavatnik Biomedical Accelerator, a research team’s lab discovery propelled to startup success.